Ardelyx, Inc. (ARDX) vs Kura Oncology, Inc. (KURA)
- Ardelyx, Inc. ARDX 3.09 −5.50%
- Kura Oncology, Inc. KURA 9.08 −6.39%
Ardelyx, Inc. and Kura Oncology, Inc. are both Biotechnology companies. Ardelyx, Inc. and Kura Oncology, Inc. are of similar size ($862.9M and $814.9M). Ardelyx, Inc. has the higher net margin (−12.4% vs −384.3%) and the lower return on invested capital (−18.6% vs 0.00%). Across the 16 metrics below, Ardelyx, Inc. leads on 12 and Kura Oncology, Inc. on 4.
Valuation
Profitability
| Metric | ARDX | KURA | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.37% | 99.35% | 65.16% |
| Operating margin | (7.86%) | (411.90%) | 0.00% |
| Net margin | (12.35%) | (384.30%) | 0.00% |
| Free cash flow margin | (3.97%) | (152.06%) | 0.00% |
| Return on equity | (38.61%) | (167.71%) | (56.36%) |
| Return on assets | (10.68%) | (46.73%) | (48.04%) |
| Return on invested capital | (18.62%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack